Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|12|7|838-846

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.12, Iss.7, 2012-09, pp. : 838-846

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 459-467

Bentham Science Publishers

Access to resources Recommend Favorite

Bottleneck limitations for microRNA-based therapeutics from bench to the bedside

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 3, 2015-03 ,pp. : 147-154

Govi-Verlag

Access to resources Recommend Favorite

Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment

By  

Current Cancer Drug Targets, Vol. 17, Iss. 9, 2017-10 ,pp. : 819-838

Bentham Science Publishers

Access to resources Recommend Favorite

Panobinostat for the treatment of multiple myeloma

By Neri Paola   Bahlis Nizar J   Lonial Sagar  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 733-747

Informa Healthcare

Access to resources Recommend Favorite

MicroRNAs in the Pathobiology of Multiple Myeloma

By  

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-09 ,pp. : 823-837

Bentham Science Publishers

Access to resources Recommend Favorite